Talking about Alzheimer’s disease: current drugs, clinical trials, and the pipeline
Sometimes, there’s an interview that we do that’s just a bit long for the regular…
February 9, 2023 - 2 minutes
Eisai
EMA accepts Marketing Authorization Application for lecanemab to treat early Alzheimer’s disease
BioArctic AB's partner Eisai says the European Medicines Agency (EMA) has accepted a marketing authorization…
January 27, 2023 - 2 minutes
Japanese companies look to reduce environmental impact
Japanese companies Astellas Pharma Inc., Eisai Co., Ltd., Daiichi Sankyo Company, Limited, and Takeda Pharmaceutical…
December 22, 2022 - 2 minutes
‘Best hope yet’ as results from Alzheimer’s drug trial reveal huge step forward
A huge step forward in dementia research has been hailed a truly historic moment by…
November 30, 2022 - 6 minutes
Positive results from Eisai and Biogen Alzheimer’s trial
Eisai Co., Ltd. and Biogen Inc. have announced positive topline results from Eisai’s large global…
September 29, 2022 - 6 minutes
